
A coalition of drugmakers is introducing new standards aimed at curbing the release of antibiotic waste into the environment amid growing concerns over drug resistance that’s been linked to more than a million annual deaths globally.
The guidelines will help ensure antibiotics are made responsibly, minimizing environmental risks, the AMR Industry Alliance said Tuesday in a statement. The group also plans to launch a certification program next spring that will allow manufacturers to show requirements have been met through independent evaluation, initially by UK-based BSI Standards Limited.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app